STAR:NSE
Strides Pharma Science Ltd
998,00 ₹
arrow_downward
-0,42%(-4,20) 1 d.
11. nov., 14:47:06 GMT+5:30 · INR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: STAR…
Atvērt
1 008,30 ₹
Augsta
1 016,00 ₹
Zema
988,00 ₹
Tirgus kapitalizācija
92,00 mljrd.
Vid. apjoms
351,03 tūkst.
Apjoms
287,01 tūkst.
Dividende
0,50%
Ceturkšņa dividendes
1,25 ₹
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 31. jūl.
Cenas/peļņas attiecība
14,92
Augstākā 52 ned.
1 260,90 ₹
Zemākā 52 ned.
768,65 ₹
Peļņa uz vienu akciju
66,90 ₹
Apgrozībā esošās akcijas
89,55 milj.
Darbinieku skaits
4 tūkst.
Atvērt
1 008,30 ₹
Augsta
1 016,00 ₹
Zema
988,00 ₹
Tirgus kapitalizācija
92,00 mljrd.
Vid. apjoms
351,03 tūkst.
Apjoms
287,01 tūkst.
Dividende
0,50%
Ceturkšņa dividendes
1,25 ₹
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 31. jūl.
Cenas/peļņas attiecība
14,92
Augstākā 52 ned.
1 260,90 ₹
Zemākā 52 ned.
768,65 ₹
Peļņa uz vienu akciju
66,90 ₹
Apgrozībā esošās akcijas
89,55 milj.
Darbinieku skaits
4 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
MarketWatch
·
pirms 16 minūtēm
Stock Market Today: Dow, S&P 500 and Nasdaq set to rise as investors seek to move past hotter-than-expected CPI; CoreWeave shares jump: live updates
Investing.com
·
pirms 1 stundas
The S&P 500 Has an Nvidia Problem
Trefis
·
pirms 2 stundām
S&P 500 Movers | Winners: CHTR, TTWO, CVS | Losers: MRNA, FSLR, NVDA
BigGo Finance
·
pirms 5 stundām
UBS Sees S&P 500 at 8,900 by End-2027 as BofA Flags Crowded Index Trade
Profils
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
Par “Strides Pharma Science Ltd”
Ģenerāldirektors-
Darbinieki3,54 tūkst.
Dibināšanas datums1990
Galvenais birojsBengalūru, Karnātaka, Indija
SektorsHealth Care
Nozare-
Tīmekļa vietnestrides.com